Antisense oligonucleotides: Towards clinical trials

被引:253
作者
Agrawal, S
机构
关键词
D O I
10.1016/0167-7799(96)10053-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Antisense oligonucleotides have the ability to selectively block disease-causing genes, thereby inhibiting production of disease-associated proteins. The specificity and application of antisense oligonucleotides have been strongly validated in animal models for various disease targets. Based on the pharmacological, pharmacodynamic and pharmacokinetic profiles, the first generation of antisense oligonucleotides - phosphorothioates - have reached the stage of human clinical trials for various diseases, While ongoing human clinical trials are being carried out to further establishing the safety and efficacy of these oligonucleotides, the experience gained is providing a basis for designing a second generation of antisense oligonucleotides.
引用
收藏
页码:376 / 387
页数:12
相关论文
共 93 条
[1]   PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J].
AGRAWAL, S ;
TEMSAMANI, J ;
TANG, JY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7595-7599
[2]  
Agrawal S, 1992, Antisense Res Dev, V2, P261
[3]   SYNTHESIS AND ANTI-HIV ACTIVITY OF OLIGORIBONUCLEOTIDES AND THEIR PHOSPHOROTHIOATE ANALOGS [J].
AGRAWAL, S ;
TANG, JY ;
SUN, D ;
SARIN, PS ;
ZAMECNIK, PC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1992, 660 :2-10
[4]   SITE-SPECIFIC EXCISION FROM RNA BY RNASE-H AND MIXED-PHOSPHATE-BACKBONE OLIGODEOXYNUCLEOTIDES [J].
AGRAWAL, S ;
MAYRAND, SH ;
ZAMECNIK, PC ;
PEDERSON, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1401-1405
[5]   ANTISENSE OLIGONUCLEOTIDES AS ANTIVIRAL AGENTS [J].
AGRAWAL, S .
TRENDS IN BIOTECHNOLOGY, 1992, 10 (05) :152-158
[6]   OLIGODEOXYNUCLEOSIDE PHOSPHORAMIDATES AND PHOSPHOROTHIOATES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS [J].
AGRAWAL, S ;
GOODCHILD, J ;
CIVEIRA, MP ;
THORNTON, AH ;
SARIN, PS ;
ZAMECNIK, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) :7079-7083
[7]   ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION [J].
AGRAWAL, S ;
ZHANG, XS ;
LU, ZH ;
ZHAO, H ;
TAMBURIN, JM ;
YAN, YM ;
CAI, HY ;
DIASIO, RB ;
HABUS, I ;
JIANG, ZW ;
IYER, RP ;
YU, D ;
ZHANG, RW .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (04) :571-576
[8]   PHARMACOKINETICS OF ANTISENSE OLIGONUCLEOTIDES [J].
AGRAWAL, S ;
TEMSAMANI, J ;
GALBRAITH, W ;
TANG, JY .
CLINICAL PHARMACOKINETICS, 1995, 28 (01) :7-16
[9]   Novel enzymatic and immunological responses to oligonucleotides [J].
Agrawal, S ;
Rustagi, PK ;
Shaw, DR .
TOXICOLOGY LETTERS, 1995, 82-3 :431-434
[10]  
Agrawal S., 1996, ANTISENSE THERAPEUTI